Ex-Bank of America Manager Pleads Guilty in Multi-Million Medicare Fraud Scheme 2026
February 18, 2026 | JacobiJournal.com – A former Bank of America branch manager in Brooklyn has pleaded guilty in federal court to charges related to a major Medicare fraud scheme. The case involves laundering millions of dollars derived from fraudulent claims submitted for glucose monitors and urinary catheters. The scheme, coordinated by a transnational criminal organization, exploited gaps in Medicare billing procedures to generate more than $10 billion in false claims. The U.S. Department of Justice reported that the former manager helped open accounts for sham medical supply companies, allowing illicit Medicare payments to flow into the financial system. By moving the funds through multiple accounts and offshore transactions, the manager aided in concealing the illegal activity and facilitating continued fraud operations. How the Medicare Fraud Scheme Operated Federal prosecutors detailed that the manager used their position to set up accounts under fictitious company names to process fraudulent claims. These accounts received Medicare payments for equipment that was either unnecessary or never delivered to patients. The illicit proceeds were then laundered through domestic and international channels to obscure their origin. Investigators noted that this method allowed the criminal organization to exploit weaknesses in banking compliance systems. By converting funds into cryptocurrency or transferring them offshore, the operation minimized detection risk and sustained high-volume fraudulent claims over an extended period. Why Medicare Fraud Cases Like This Matter The case highlights the impact of Medicare fraud on both taxpayers and public health. Fraudulent claims for medical equipment not only divert billions in government funds but also endanger patients when unnecessary devices are provided. Federal authorities have emphasized that targeting money laundering linked to Medicare fraud is critical to maintaining program integrity. By pursuing intermediaries who facilitate fraud, including financial professionals, the DOJ demonstrates the importance of accountability at multiple levels. This enforcement approach deters similar schemes and reinforces compliance requirements for both banks and healthcare providers. What the Conviction Means for Accountability The former branch manager pleaded guilty to conspiracy to commit money laundering, which carries potential federal prison time of up to 20 years. Sentencing will consider the magnitude of the scheme, the amount laundered, and the individual’s role in enabling the fraud. Other participants in the larger criminal network remain under investigation, with law enforcement leveraging cross-border cooperation to identify additional suspects. The case serves as a warning to professionals in finance and healthcare that involvement in Medicare fraud carries severe consequences. Compliance with anti-money laundering protocols and careful monitoring of billing practices are essential to prevent complicity in fraudulent activities. How Fraud Targets Durable Medical Equipment Durable medical equipment such as glucose monitors and urinary catheters is frequently exploited in Medicare fraud schemes because these products are billed in large volumes with limited oversight. Criminal networks submit inflated or fictitious claims under the guise of medical necessity, generating significant illicit revenue. Healthcare fraud experts note that the combination of high-volume billing and weak verification processes creates an environment where fraudulent claims can go undetected. Strengthening internal controls and improving monitoring of Medicare payments are essential measures to reduce vulnerability. Preventing and Reporting Medicare Fraud Financial institutions and healthcare providers can mitigate the risk of Medicare fraud by implementing strict Know-Your-Customer (KYC) procedures and conducting thorough reviews of billing patterns. Detecting anomalies early and reporting suspicious activity to authorities helps prevent large-scale losses. Patients are also encouraged to monitor their Medicare Summary Notices and report discrepancies. Awareness of fraudulent billing practices empowers beneficiaries to protect their accounts and contributes to broader efforts to combat healthcare fraud. For complete details on this case, read the official DOJ press release. FAQs: About the Medicare Fraud What is Medicare fraud? Medicare fraud occurs when individuals or organizations submit false claims or perform billing schemes to obtain payments they are not entitled to under Medicare programs. How did the former Bank of America manager participate? The manager opened bank accounts for fictitious medical supply companies, allowing fraudulent Medicare payments to flow into the financial system before being laundered. Why are glucose monitors and urinary catheters often targeted in fraud? These devices are billed in high volumes and receive limited oversight, making it easier for fraudsters to submit claims for unnecessary or undelivered equipment. What penalties exist for Medicare fraud convictions? Convictions can result in decades of federal prison time, fines, and orders for restitution depending on the scale of the fraud and the specific charges. Stay informed on major healthcare and financial fraud investigations by subscribing to JacobiJournal.com today. 🔎 Read More from JacobiJournal.com:
Mississippi Businessman Admits Guilt in $19M Medicare Fraud Scheme
January 15, 2026 | JacobiJournal.com — A Mississippi entrepreneur recently admitted to orchestrating a Medicare fraud scheme spanning several years through fraudulent claims for durable medical equipment. Investigators say the defendant controlled multiple companies and arranged unnecessary medical equipment orders to generate false billing. The operation focused on high-value items like orthotic braces, using falsified prescriptions and kickbacks to secure compliance from certain medical professionals. Over several years, the scheme accumulated approximately $19 million in fraudulent claims submitted to federal health care programs. Why Federal Authorities Acted Federal prosecutors highlighted the scheme as a significant threat to Medicare’s integrity. By using multiple companies and exploiting medical orders for financial gain, the defendant created systemic vulnerabilities that could encourage similar abuse if left unchecked. Authorities also emphasized that the investigation aligns with ongoing federal initiatives to target health care and Medicare fraud nationwide, deterring abuse of both federal and private insurance programs. What the Guilty Plea Means The businessman pled guilty to conspiracy to commit health care or Medicare fraud. He now faces potential prison time, restitution, and forfeiture of proceeds gained through the scheme. Federal prosecutors will determine sentencing details during an upcoming hearing, emphasizing both punishment and recovery of stolen funds. This plea reinforces the federal government’s commitment to prosecuting individuals who profit from fraudulent medical billing and serves as a warning to those considering similar conduct. How This Case Impacts Health Care Providers Increased Scrutiny: Providers and business owners involved in durable medical equipment billing should anticipate tighter federal audits. The case illustrates that federal authorities remain vigilant in addressing Medicare fraud, particularly in sectors such as durable medical equipment that have historically been vulnerable to abuse. Prosecutors continue to prioritize cases involving organized schemes, shell entities, and the misuse of provider credentials, signaling that enforcement efforts remain aggressive and sustained. For health care providers and business operators, the case serves as a clear warning that regulatory compliance is not optional. Exposure to Medicare fraud investigations can arise from inadequate oversight, improper billing practices, or failures in medical necessity documentation, with violations carrying serious civil and criminal consequences even years after claims are submitted. As federal enforcement intensifies, health care businesses are increasingly expected to adopt proactive compliance strategies. Implementing routine internal audits, staff training on Medicare billing requirements, and clear reporting protocols can help reduce the risk of Medicare fraud violations and demonstrate good-faith efforts to comply with federal law. Read the official DOJ release on the case here for detailed facts and updates. FAQs: About the $19M Health Care Fraud Conspiracy Who pled guilty in this case? A Mississippi businessman who controlled several durable medical equipment companies pleaded guilty to orchestrating a $19 million Medicare fraud scheme. According to federal prosecutors, the defendant used his ownership and control of multiple entities to submit fraudulent claims for medically unnecessary equipment, directing billing operations designed to maximize improper reimbursements from the Medicare program. What methods were used to commit the Medicare fraud? The defendant submitted unnecessary medical equipment claims and used kickbacks to secure prescriptions that beneficiaries did not require. What penalties could the defendant face? The guilty plea exposes him to potential prison time, restitution, and forfeiture of funds obtained through fraudulent activity. Which federal agencies investigated the Medicare fraud scheme? The FBI and the Department of Health and Human Services Office of Inspector General (HHS‑OIG) led the investigation, with prosecution by the U.S. Attorney’s Office and DOJ Criminal Division Fraud Section. Stay informed. Subscribe to JacobiJournal.com for timely coverage of health care fraud and federal enforcement actions. 🔎 Read More from JacobiJournal.com:
$100M Adderall Distribution Fraud: Digital Health CEO and President Convicted
December 10, 2025 | JacobiJournal.com — In a high-profile case highlighting the dangers of unregulated telemedicine, two top executives of a California digital health company have been convicted in a $100 million Adderall distribution fraud scheme. Ruthia He, the company’s founder and CEO, along with David Brody, the clinical president, were found guilty of illegally distributing stimulants online and submitting fraudulent health care claims. Authorities say the scheme not only defrauded federal programs but also endangered patients by creating an unmonitored pipeline for controlled substances. How the Adderall Distribution Fraud Scheme Operated Federal prosecutors in San Francisco announced that Ruthia He, founder and CEO of Done, and David Brody, the company’s clinical president, were convicted for orchestrating a massive Adderall distribution fraud. The executives ran an online telehealth platform, misleading patients into subscribing for Adderall and other stimulant medications. Authorities reported that the defendants submitted fraudulent claims to health care programs while simultaneously targeting patients through social media advertising. Over the course of the scheme, Done distributed tens of millions of pills, generating profits while endangering public safety. He was also convicted of conspiring to obstruct justice. Why Telehealth Became a Vehicle for Fraud Investigators noted that telehealth platforms, while designed to increase access to care, can be exploited if proper oversight is absent. He and Brody allegedly took advantage of lax online prescription regulations, offering easy access to controlled substances without thorough medical evaluation. Officials warn that these practices undermine trust in digital health solutions and highlight the importance of strict telemedicine compliance. “Patient safety must never be compromised for profit,” emphasized Acting Assistant Attorney General Matthew D. Galeotti. What Officials Are Saying About the Case U.S. Attorney Craig H. Missakian stated that the convictions “underscore the ethical responsibility of medical professionals to prioritize patient wellbeing over financial gain.” DEA and HHS-OIG investigators added that this is one of the largest telehealth-related controlled substance fraud cases in recent history. The case also reflects the growing need for federal and state regulators to monitor online prescription practices, especially as digital health services continue to expand nationwide. How Patients and the Health Care System Were Impacted The Adderall distribution fraud carried out by the company had serious consequences for patients, including increased risks of addiction, misuse, and overdose. Health care programs were defrauded as the company submitted millions of dollars in false claims. Experts warn that this case serves as a cautionary tale for patients using online health services and for regulators working to protect public health. Read the full official DOJ press release here for detailed information. FAQs: $100M Adderall Fraud Case Who were convicted in the $100M Adderall distribution fraud case? Ruthia He, CEO of Done, and David Brody, the company’s clinical president, were convicted for illegal Adderall distribution and health care fraud. How did the company illegally distribute Adderall? The executives used an online telehealth platform and social media advertising to offer subscriptions for Adderall, bypassing proper medical evaluation. Which government agencies investigated the case? DOJ, DEA, HHS-OIG, IRS Criminal Investigation, and the Northern District of California U.S. Attorney’s Office led the investigation. What were the consequences of the Adderall distribution fraud for patients and the health care system? The Adderall distribution fraud exposed patients to risks of addiction, misuse, and overdose, while health care programs were defrauded of millions of dollars through false claims. This case highlights the need for stronger oversight of telehealth services and controlled substance prescriptions. Protect yourself and your community from online prescription scams. Subscribe to JacobiJournal.com for the latest updates on health care fraud, regulatory oversight, and digital health news. 🔎 Read More from JacobiJournal.com:
How a Michigan Pharmacist and His Brother Pulled Off a $15 Million Health Care Fraud Scheme
December 1, 2025 | JacobiJournal.com — health care and wire fraud. The duo orchestrated a complex scheme targeting Medicare, Medicaid, and private insurers, resulting in over $15 million in losses. The case underscores the persistent threat of health care fraud in pharmacies and the growing scrutiny by federal authorities. What the Fraud Entailed Federal investigators revealed that from 2010 to 2019, Raad Kouza, 59, and his brother Ramis Kouza, 46, submitted fraudulent claims for prescription medications they never dispensed at their Michigan pharmacies. Key points include: As a result, the scheme cost federal and private insurers more than $15 million. Why the Court Issued Prison Sentences In November 2024, a federal jury convicted the brothers of conspiracy to commit health care fraud and wire fraud. At sentencing: Federal prosecutors emphasized that these sentences reflect the severity of deliberate fraud targeting government health programs. How Federal Agencies Investigated the Case The case was investigated by the FBI Detroit Field Office and the HHS Office of Inspector General (OIG). It was prosecuted by the Criminal Division’s Health Care Fraud Strike Force Program, which has charged thousands of defendants nationwide for defrauding federal health programs. The DOJ notes that ongoing oversight by CMS and HHS-OIG aims to prevent similar fraud schemes and hold providers accountable. For readers seeking official details on health care fraud enforcement, visit the DOJ Health Care Fraud Unit. Why This Case Matters Experts say the Kouza case highlights systemic vulnerabilities in pharmacy billing and inventory oversight. It also demonstrates that coordinated federal investigation and prosecution can recover losses and deter future fraudulent activity. Health care providers are encouraged to strengthen internal audits, compliance programs, and reporting mechanisms to reduce exposure to similar legal risks. FAQ: Understanding Health Care Fraud by Pharmacists How do pharmacists commit health care fraud? Fraud can occur through billing for medications not dispensed, overcharging insurers, or falsifying inventory records, as demonstrated in this case. What are the penalties for health care fraud? Convictions can include prison time, restitution, forfeiture, and professional license sanctions, depending on the scale of the scheme. How are pharmacy fraud cases investigated? Federal authorities such as the FBI and HHS-OIG conduct audits, review billing records, and analyze pharmacy operations to detect discrepancies. Can victims recover losses from health care fraud? Yes. Courts often order restitution to recover losses for government programs and insurers impacted by fraudulent schemes. Stay informed on health care fraud and insurance investigations — subscribe to JacobiJournal.com for expert reporting and timely updates. 🔎 Read More from JacobiJournal.com:
Founder and Clinical President of Digital Health Company Convicted in $100M Adderall Fraud
November 26, 2025 | JacobiJournal.com — A federal jury in San Francisco has convicted Ruthia He, founder and CEO of California-based digital health company Done, and David Brody, the company’s clinical president, for orchestrating a multi-million-dollar online Adderall distribution and health care fraud scheme. The case exposed how telehealth can be exploited to bypass medical safeguards and submit fraudulent claims to insurers. How the Digital Health Scheme Operated He and Brody allegedly built a digital health business model centered on subscription-based access to Adderall and other stimulants. Investigators found that the company: The scheme reportedly dispensed over 40 million pills and generated illegal revenue exceeding $100 million, including approximately $14 million obtained from Medicare, Medicaid, and commercial insurers through fraudulent claims. Why Regulators Took Action Federal authorities emphasized the danger to patient safety and integrity of the health care system. Statements from the DEA, HHS-OIG, and the Justice Department described the defendants’ actions as: The case demonstrates the risks of digital health platforms that lack adequate oversight and how these systems can be misused to commit large-scale prescription fraud. What This Means for Patients and the Industry This conviction underscores several critical lessons for telehealth and digital medicine: Medical necessity must guide prescriptions: Doctors and providers cannot prioritize revenue over patient care. Health care providers, patients, and investors should be aware that telehealth innovation does not excuse compliance failures or abuse. For more information on federal enforcement and health care fraud investigations, the Department of Justice Health Care Fraud Unit provides updates here. FAQs: Digital Health Adderall Fraud How did the digital health company distribute Adderall illegally? The company used online subscriptions, auto-refill features, minimal clinical interaction, and paid nurses to refill prescriptions without proper oversight. What penalties do the convicted executives face? Ruthia He and David Brody each face up to 20 years in prison on controlled substance charges, as well as additional penalties for health care fraud and obstruction of justice. How did the defendants defraud insurers? They submitted false prior authorization requests claiming adherence to DSM-5 protocols and urine drug testing, which caused Medicare, Medicaid, and commercial insurers to pay over $14 million. Why is this case important for telehealth regulation? It highlights the risks of unchecked digital health platforms and emphasizes that patient safety and compliance must guide telehealth practices. Stay informed on health care fraud and telehealth abuse. Subscribe to JacobiJournal.com for exclusive investigative reports and timely updates. 🔎 Read More from JacobiJournal.com:
Second Circuit Orders Resentencing in $600M Medical Billing Fraud Case
September 12, 2025 | JacobiJournal.com — A federal appeals court has affirmed the conviction of a Long Island medical biller who orchestrated a $600 million medical billing fraud scheme but sent the case back to the trial court for resentencing. The ruling underscores the judiciary’s continued focus on accountability in one of the largest medical billing fraud cases ever prosecuted. Conviction Upheld, But Sentencing Reconsidered The Second Circuit panel ruled that the evidence of fraud was overwhelming, leaving no question about the defendant’s guilt. However, the court determined that errors in the original sentencing required the case to be remanded for further review. The decision leaves the conviction intact while opening the door for a new assessment of the punishment. $600 Million Fraud Scheme Detailed According to federal prosecutors, the biller submitted fraudulent insurance claims totaling hundreds of millions of dollars and went so far as to impersonate professional athletes, including an NBA player and NFL figures, to further the scheme. The elaborate fraud exploited weaknesses in the medical billing system, resulting in one of the largest recoveries ever pursued in a single case. Broader Implications for Health Care Fraud Enforcement Legal analysts say the ruling highlights the importance of strong sentencing procedures in health care fraud cases. It also reinforces the government’s aggressive stance against schemes that threaten the stability of insurance systems and increase costs for policyholders nationwide. With medical billing fraud continuing to rise, this case may set a standard for future prosecutions. For official documentation and case details, readers can review filings at the U.S. Court of Appeals for the Second Circuit. FAQs: $600M Medical Billing Fraud Case What was the fraud about? The defendant submitted fraudulent insurance claims worth approximately $600 million, using false identities and impersonations to support the scheme. What did the Second Circuit decide? The appeals court affirmed the conviction but remanded the case for resentencing due to procedural errors in the original judgment. Why is resentencing significant? It ensures sentencing procedures meet federal standards, giving the defendant a fair hearing while maintaining accountability for large-scale fraud. How does this affect future health care fraud cases? The ruling reinforces both the seriousness of medical billing fraud and the need for careful sentencing, likely influencing how future fraud prosecutions are handled. Stay informed on major insurance fraud and health care litigation by subscribing to JacobiJournal.com. 🔎 Read More from JacobiJournal.com: